Brief report: EGFR L858M/L861Q cis mutations confer selective sensitivity to afatinib

Por Saxon, Jamie A., Sholl, Lynette M., Jänne, Pasi A.
Publicado no J Thorac Oncol (2017)

ITPKA Gene Body Methylation Regulates Gene Expression and Serves as an Early Diagnostic Marker in Lung and Other Cancers

Por Wang, Yi-Wei, Ma, Xiaotu, Zhang, Yu-An, Wang, Mei-Jung, Yatabe, Yasushi, Lam, Stephen, Girard, Luc, Chen, Jeou-Yuan, Gazdar, Adi F.
Publicado no J Thorac Oncol (2016)

Clinical Efficacy and Predictive Molecular Markers of Neoadjuvant Gemcitabine and Pemetrexed in Resectable Non-Small-Cell Lung Cancer

Por Bepler, Gerold, Sommers, K. Eric, Cantor, Alan, Li, Xueli, Sharma, Anupama, Williams, Charles, Chiappori, Alberto, Haura, Eric, Antonia, Scott, Tanvetyanon, Tawee, Simon, George, Obasaju, Coleman, Robinson, Lary A.
Publicado em 2008

MicroRNAs in the Pathogenesis of Lung Cancer

Por Wu, Xin, Piper-Hunter, Melissa G., Crawford, Melissa, Nuovo, Gerard J., Marsh, Clay B., Otterson, Gregory A., Nana-Sinkam, Serge P.
Publicado em 2009

A phase I/II study of GTI-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer (NSCLC). A study of the PMH Phase II Consortium

Por Leighl, NB, Laurie, SA, Chen, XE, Ellis, P, Shepherd, FA, Knox, JJ, Goss, G, Burkes, RL, Pond, GR, Dick, C, Yen, Y, Zwiebel, JA, Moore, MJ
Publicado em 2009

Multi-Modality Mediastinal Staging for Lung Cancer Among Medicare Beneficiaries

Por Farjah, Farhood, Flum, David R., Ramsey, Scott D., Heagerty, Patrick J., Symons, Rebecca Gaston, Wood, Douglas E.
Publicado em 2009

Chronic obstructive lung diseases and risk of non-small cell lung cancer in women

Por Schwartz, Ann G., Cote, Michele L., Wenzlaff, Angela S., Van Dyke, Alison, Chen, Wei, Ruckdeschel, John C., Gadgeel, Shirish, Soubani, Ayman O.
Publicado em 2009

A Pessimistic Explanatory Style is Prognostic for Poor Lung Cancer Survival

Por Novotny, Paul, Colligan, Robert C., Szydlo, Daniel W., Clark, Matthew M., Rausch, Sarah, Wampfler, Jason, Sloan, Jeff A., Yang, Ping
Publicado em 2010

Phase II study of cediranib (AZD 2171), an inhibitor of the vascular endothelial growth factor receptor, for second-line therapy of small cell lung cancer (NCI # 7097)

Por Ramalingam, Suresh S., Belani, Chandra P., Mack, Philip C., Vokes, Everett E., Longmate, Jeffrey, Govindan, Ramaswamy, Koczywas, Marianna, Ivy, S. Percy, Gandara, David R.
Publicado em 2010

A Structured Exercise Program for Patients with Advanced Non-small Cell Lung Cancer

Por Temel, Jennifer S., Greer, Joseph A., Goldberg, Sarah, Vogel, Paula Downes, Sullivan, Michael, Pirl, William F., Lynch, Thomas J., Christiani, David C., Smith, Matthew R.
Publicado em 2009

The HIV Protease Inhibitor Ritonavir Inhibits Lung Cancer Cells, in part, by Inhibition of Survivin

Por Srirangam, Anjaiah, Milani, Monica, Mitra, Ranjana, Guo, Zhijun, Rodriguez, Mariangellys, Kathuria, Hitesh, Fukuda, Seiji, Rizzardi, Anthony, Schmechel, Stephen, Skalnik, David G., Pelus, Louis M., Potter, David A.
Publicado em 2011

A smoking cessation intervention for thoracic surgery and oncology clinics: a pilot trial

Por Park, Elyse R., Japuntich, Sandra, Temel, Jennifer, Lanuti, Michael, Pandiscio, Jennifer, Hilgenberg, Joanna, Davies, Diane, Dresler, Carolyn, Rigotti, Nancy A.
Publicado em 2011

BV6, an IAP antagonist, activates apoptosis and enhances radiosensitization of non-small cell lung carcinoma in vitro

Por Li, Wenyan, Li, Bo, Giacalone, Nicholas J., Torossian, Artour, Sun, Yunguang, Niu, Kathy, Lin-Tsai, Opal, Lu, Bo
Publicado em 2011

Thoroughness of Mediastinal Staging in Stage IIIA Non-Small Cell Lung Cancer

Por Vest, Michael T., Tanoue, Lynn, Soulos, Pamela R., Kim, Anthony W., Detterbeck, Frank, Morgensztern, Daniel, Gross, Cary P.
Publicado em 2012

Combining the Multi-Targeted Tyrosine Kinase Inhibitor Vandetanib with the Anti-Estrogen Fulvestrant Enhances its Anti-tumor Effect in Non-Small Cell Lung Cancer

Por Siegfried, Jill M., Gubish, Christopher T., Rothstein, Mary E., Henry, Cassandra, Stabile, Laura P.
Publicado em 2012

Defining Local-regional Control and Its Importance in Locally Advanced Non-small Cell Lung Carcinoma: An RTOG Analysis

Por Machtay, Mitchell, Paulus, Rebecca, Moughan, Jennifer, Komaki, Ritsuko, Bradley, Jeffrey, Choy, Hak, Albain, Kathy, Movsas, Benjamin, Sause, William T., Curran, Walter J.
Publicado em 2012

Frequency of EGFR and KRAS Mutations in Lung Adenocarcinomas in African-Americans

Por Reinersman, J. Matthew, Johnson, Melissa L., Riely, Gregory J., Chitale, Dhananjay A., Nicastri, Anthony D., Soff, Gerald A., Schwartz, Ann G., Sima, Camelia S., Ayalew, Getinet, Lau, Christopher, Zakowski, Maureen F., Rusch, Valerie W., Ladanyi, Marc, Kris, Mark G.
Publicado em 2011

Brief report: Screening for germline EGFR T790M mutations through lung cancer genotyping

Por Oxnard, Geoffrey R., Miller, Vincent A., Robson, Mark E., Azzoli, Christopher G., Pao, William, Ladanyi, Marc, Arcila, Maria E.
Publicado em 2012

Automated Identification of Patients with Pulmonary Nodules in an Integrated Health System Using Administrative Health Plan Data, Radiology Reports, and Natural Language Processing

Por Danforth, Kim N., Early, Megan I., Ngan, Sharon, Kosco, Anne E., Zheng, Chengyi, Gould, Michael K.
Publicado em 2012

Lungs don’t forget: Comparison of the KRAS and EGFR mutation profile and survival of “collegiate smokers” and never smokers with advanced lung cancers

Por Varghese, Anna M., Sima, Camelia S., Chaft, Jamie E., Johnson, Melissa L., Riely, Gregory J., Ladanyi, Marc, Kris, Mark G.
Publicado em 2013